Prothena Price To Sales Ratio vs Inventory Turnover Analysis

PRTA Stock

USD 15.14 0.60 3.81%

Prothena Plc financial indicator trend analysis is much more than just breaking down Prothena plc prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Prothena plc is a good investment. Please check the relationship between Prothena Plc Price To Sales Ratio and its Inventory Turnover accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

Price To Sales Ratio vs Inventory Turnover

Price To Sales Ratio vs Inventory Turnover Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Prothena plc Price To Sales Ratio account and Inventory Turnover. At this time, the significance of the direction appears to have almost no relationship.

The correlation between Prothena Plc's Price To Sales Ratio and Inventory Turnover is 0.14. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Inventory Turnover in the same time period over historical financial statements of Prothena plc, assuming nothing else is changed. The correlation between historical values of Prothena Plc's Price To Sales Ratio and Inventory Turnover is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Prothena plc are associated (or correlated) with its Inventory Turnover. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Inventory Turnover has no effect on the direction of Price To Sales Ratio i.e., Prothena Plc's Price To Sales Ratio and Inventory Turnover go up and down completely randomly.

Correlation Coefficient

0.14

Relationship Direction	Positive
Relationship Strength	Insignificant

View All Relationships

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Prothena plc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Prothena Plc sales, a figure that is much harder to manipulate than other Prothena plc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Most indicators from Prothena Plc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Prothena plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.As of December 29, 2024, Selling General Administrative is expected to decline to about 34.6 M. The current year's Tax Provision is expected to grow to about (12.8 M)

	2021	2022	2023	2024 (projected)
Total Operating Expenses	128.6M	185.5M	282.4M	296.5M
Cost Of Revenue	82.3M	6.7M	220.6M	231.6M

Total Operating Expenses Cost Of Revenue

Prothena Plc fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Other Assets	Total Liab	Property Plant Equipment	Property Plant And Equipment Net	Non Current Assets Total	Non Currrent Assets Other	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Net Debt	Retained Earnings	Cash	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Inventory	Common Stock
Common Stock Shares Outstanding		0.94	0.05	0.77	0.86	0.76	0.5	0.76	0.9	0.23	0.42	0.7	0.67	0.78	0.74	0.98	-0.14	0.93	-0.87	-0.9	0.93	0.93	0.28	1.0	-0.25	0.99
Total Assets	0.94		0.07	0.79	0.98	0.6	0.53	0.68	0.78	0.31	0.41	0.69	0.8	0.63	0.81	0.95	0.04	1.0	-0.92	-0.79	0.98	0.98	0.26	0.95	-0.27	0.96
Other Current Liab	0.05	0.07		0.43	0.17	-0.23	0.47	0.21	-0.25	-0.3	-0.26	-0.14	0.12	-0.41	0.36	0.06	-0.22	0.1	-0.19	-0.07	0.11	0.11	0.33	0.06	-0.3	0.09
Total Current Liabilities	0.77	0.79	0.43		0.79	0.49	0.88	0.85	0.57	0.28	0.35	0.62	0.72	0.39	0.91	0.79	-0.17	0.8	-0.87	-0.8	0.82	0.82	0.62	0.79	-0.58	0.83
Total Stockholder Equity	0.86	0.98	0.17	0.79		0.45	0.57	0.6	0.62	0.27	0.31	0.59	0.81	0.45	0.84	0.87	0.1	0.98	-0.91	-0.68	0.96	0.96	0.3	0.87	-0.33	0.89
Other Liab	0.76	0.6	-0.23	0.49	0.45		0.28	0.74	0.87	-0.05	0.21	0.44	0.34	0.89	0.49	0.78	-0.36	0.61	-0.65	-0.9	0.62	0.62	0.3	0.76	-0.22	0.77
Accounts Payable	0.5	0.53	0.47	0.88	0.57	0.28		0.74	0.28	0.28	0.29	0.51	0.51	0.13	0.8	0.53	-0.02	0.54	-0.64	-0.61	0.55	0.55	0.85	0.54	-0.83	0.57
Other Assets	0.76	0.68	0.21	0.85	0.6	0.74	0.74		0.7	0.13	0.28	0.58	0.61	0.6	0.77	0.81	-0.3	0.68	-0.76	-0.92	0.7	0.7	0.59	0.78	-0.49	0.81
Total Liab	0.9	0.78	-0.25	0.57	0.62	0.87	0.28	0.7		0.34	0.57	0.76	0.55	0.97	0.47	0.88	-0.15	0.75	-0.67	-0.87	0.74	0.74	0.08	0.88	-0.02	0.87
Property Plant Equipment	0.23	0.31	-0.3	0.28	0.27	-0.05	0.28	0.13	0.34		0.93	0.81	0.39	0.3	0.07	0.19	0.48	0.24	-0.11	-0.12	0.21	0.21	-0.08	0.23	0.04	0.21
Property Plant And Equipment Net	0.42	0.41	-0.26	0.35	0.31	0.21	0.29	0.28	0.57	0.93		0.9	0.37	0.55	0.09	0.36	0.39	0.33	-0.19	-0.33	0.3	0.3	-0.07	0.41	0.07	0.38
Non Current Assets Total	0.7	0.69	-0.14	0.62	0.59	0.44	0.51	0.58	0.76	0.81	0.9		0.64	0.68	0.41	0.68	0.2	0.62	-0.51	-0.63	0.61	0.61	0.15	0.71	-0.15	0.69
Non Currrent Assets Other	0.67	0.8	0.12	0.72	0.81	0.34	0.51	0.61	0.55	0.39	0.37	0.64		0.39	0.7	0.73	-0.07	0.79	-0.76	-0.59	0.81	0.81	0.19	0.68	-0.22	0.74
Non Current Liabilities Total	0.78	0.63	-0.41	0.39	0.45	0.89	0.13	0.6	0.97	0.3	0.55	0.68	0.39		0.31	0.76	-0.14	0.6	-0.53	-0.8	0.6	0.6	0.0	0.76	0.07	0.74
Other Current Assets	0.74	0.81	0.36	0.91	0.84	0.49	0.8	0.77	0.47	0.07	0.09	0.41	0.7	0.31		0.77	-0.19	0.84	-0.94	-0.76	0.87	0.87	0.65	0.76	-0.64	0.81
Other Stockholder Equity	0.98	0.95	0.06	0.79	0.87	0.78	0.53	0.81	0.88	0.19	0.36	0.68	0.73	0.76	0.77		-0.16	0.94	-0.89	-0.92	0.94	0.94	0.31	0.99	-0.27	0.99
Property Plant And Equipment Gross	-0.14	0.04	-0.22	-0.17	0.1	-0.36	-0.02	-0.3	-0.15	0.48	0.39	0.2	-0.07	-0.14	-0.19	-0.16		0.01	0.2	0.31	-0.14	-0.14	-0.11	-0.11	0.07	-0.16
Total Current Assets	0.93	1.0	0.1	0.8	0.98	0.61	0.54	0.68	0.75	0.24	0.33	0.62	0.79	0.6	0.84	0.94	0.01		-0.94	-0.79	0.98	0.98	0.29	0.94	-0.3	0.95
Net Debt	-0.87	-0.92	-0.19	-0.87	-0.91	-0.65	-0.64	-0.76	-0.67	-0.11	-0.19	-0.51	-0.76	-0.53	-0.94	-0.89	0.2	-0.94		0.84	-0.97	-0.97	-0.47	-0.88	0.47	-0.92
Retained Earnings	-0.9	-0.79	-0.07	-0.8	-0.68	-0.9	-0.61	-0.92	-0.87	-0.12	-0.33	-0.63	-0.59	-0.8	-0.76	-0.92	0.31	-0.79	0.84		-0.81	-0.81	-0.46	-0.91	0.39	-0.92
Cash	0.93	0.98	0.11	0.82	0.96	0.62	0.55	0.7	0.74	0.21	0.3	0.61	0.81	0.6	0.87	0.94	-0.14	0.98	-0.97	-0.81		1.0	0.32	0.93	-0.33	0.95
Cash And Short Term Investments	0.93	0.98	0.11	0.82	0.96	0.62	0.55	0.7	0.74	0.21	0.3	0.61	0.81	0.6	0.87	0.94	-0.14	0.98	-0.97	-0.81	1.0		0.32	0.93	-0.33	0.95
Net Receivables	0.28	0.26	0.33	0.62	0.3	0.3	0.85	0.59	0.08	-0.08	-0.07	0.15	0.19	0.0	0.65	0.31	-0.11	0.29	-0.47	-0.46	0.32	0.32		0.33	-0.98	0.35
Common Stock Total Equity	1.0	0.95	0.06	0.79	0.87	0.76	0.54	0.78	0.88	0.23	0.41	0.71	0.68	0.76	0.76	0.99	-0.11	0.94	-0.88	-0.91	0.93	0.93	0.33		-0.3	0.99
Inventory	-0.25	-0.27	-0.3	-0.58	-0.33	-0.22	-0.83	-0.49	-0.02	0.04	0.07	-0.15	-0.22	0.07	-0.64	-0.27	0.07	-0.3	0.47	0.39	-0.33	-0.33	-0.98	-0.3		-0.32
Common Stock	0.99	0.96	0.09	0.83	0.89	0.77	0.57	0.81	0.87	0.21	0.38	0.69	0.74	0.74	0.81	0.99	-0.16	0.95	-0.92	-0.92	0.95	0.95	0.35	0.99	-0.32

Click cells to compare fundamentals

Prothena Plc Account Relationship Matchups

Prothena Plc fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	39.9M	39.9M	48.5M	47.4M	53.2M	35.1M
Total Assets	419.3M	333.0M	609.4M	758.0M	696.4M	414.8M
Other Current Liab	6.8M	10.7M	10.2M	16.5M	29.3M	30.7M
Total Current Liabilities	17.7M	25.8M	33.5M	50.1M	56.9M	59.7M
Total Stockholder Equity	272.9M	184.0M	466.0M	622.0M	561.4M	325.8M
Accounts Payable	1.2M	4.1M	3.7M	9.3M	25.4M	26.7M
Other Assets	13.7M	31.1M	10.4M	30.9M	35.6M	37.3M
Total Liab	146.3M	149.0M	143.3M	136.0M	135.0M	89.0M
Property Plant Equipment	3.9M	2.6M	2.0M	8.0M	9.2M	16.9M
Property Plant And Equipment Net	27.1M	20.4M	14.1M	8.0M	16.0M	22.5M
Non Current Assets Total	40.9M	33.7M	24.6M	38.9M	57.1M	36.0M
Non Currrent Assets Other	3.8M	1.7M	3.4M	12.7M	7.2M	4.7M
Liabilities And Stockholders Equity	419.3M	333.0M	609.4M	758.0M	696.4M	446.4M
Non Current Liabilities Total	128.6M	123.1M	109.9M	85.8M	78.1M	67.8M
Other Current Assets	2.7M	3.9M	10.7M	15.6M	15.3M	16.1M
Other Stockholder Equity	944.4M	966.6M	1.2B	1.5B	1.5B	822.4M
Property Plant And Equipment Gross	27.1M	20.4M	14.1M	8.0M	23.4M	22.3M
Total Current Assets	378.4M	299.3M	584.8M	719.1M	639.3M	410.5M
Net Debt	(352.8M)	(277.5M)	(566.8M)	(703.9M)	(607.0M)	(576.6M)
Retained Earnings	(671.9M)	(783.0M)	(716.1M)	(833.0M)	(980.0M)	(931.0M)
Cash	375.7M	295.4M	579.1M	710.4M	618.8M	437.9M
Cash And Short Term Investments	375.7M	295.4M	579.1M	710.4M	618.8M	437.9M
Net Receivables	68K	15K	13K	62K	5.2M	5.4M
Net Tangible Assets	272.9M	184.0M	466.0M	622.0M	715.3M	381.1M
Retained Earnings Total Equity	(598.0M)	(671.9M)	(783.0M)	(716.1M)	(644.4M)	(676.7M)
Capital Surpluse	920.6M	944.4M	966.6M	1.2B	1.4B	801.6M
Deferred Long Term Liab	254K	110.4M	110.2M	102.9M	118.4M	124.3M
Short Term Debt	5.1M	11.0M	11.9M	12.9M	2.2M	2.1M
Non Current Liabilities Other	18.4M	12.9M	6.9M	553K	497.7K	472.8K
Short Long Term Debt Total	22.9M	17.8M	12.3M	6.5M	11.8M	22.7M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

When determining whether Prothena plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Prothena Plc's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prothena Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prothena Plc Stock:

How To Invest In Prothena

Details

Is Prothena Stock a good investment?

Details

What is Prothena Plc's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Prothena plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

For information on how to trade Prothena Stock refer to our How to Trade Prothena Stock guide.

You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Prothena Plc. If investors know Prothena will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Prothena Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.46)

Revenue Per Share

2.482

Quarterly Revenue Growth

(0.99)

Return On Assets

(0.16)

Return On Equity

(0.23)

The market value of Prothena plc is measured differently than its book value, which is the value of Prothena that is recorded on the company's balance sheet. Investors also form their own opinion of Prothena Plc's value that differs from its market value or its book value, called intrinsic value, which is Prothena Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Prothena Plc's market value can be influenced by many factors that don't directly affect Prothena Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Prothena Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Prothena Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Prothena Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Prothena Price To Sales Ratio vs Inventory Turnover Analysis

Price To Sales Ratio vs Inventory Turnover

Price To Sales Ratio vs Inventory Turnover Correlation Analysis

Correlation Coefficient

Price To Sales Ratio

Inventory Turnover

Prothena Plc fundamental ratios Correlations

Prothena Plc Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Prothena Plc fundamental ratios Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Common Stock Total Equity	+ 1.0	Common Stock Shares Outstanding
Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Common Stock	+ 0.99	Common Stock Shares Outstanding
Common Stock Total Equity	+ 0.99	Other Stockholder Equity
Common Stock	+ 0.99	Other Stockholder Equity

Inventory	- 0.98	Net Receivables
Cash And Short Term Investments	- 0.97	Net Debt
Cash	- 0.97	Net Debt
Net Debt	- 0.94	Total Current Assets
Net Debt	- 0.94	Other Current Assets
Common Stock	- 0.92	Retained Earnings